We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

ProBioGen in Biosimilar Deal with Bio Farma Indonesia


Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "ProBioGen in Biosimilar Deal with Bio Farma Indonesia"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
 

ProBioGen AG and Bio Farma have signed an agreement for the development of a biosimilar Trastuzumab for cancer treatment. The goal of the co-operation is the supply of the Indonesian patients with cost-effective high quality biopharmaceuticals.

Under the terms of the agreement ProBioGen will develop a highly efficient manufacturing process based on a specifically designed recombinant CHO-cell line, conduct engineering runs and the industrial scale-up.

The turn-key process, including analytics, will then be transferred to Indonesia to enable local market production. The agreement is fee-for-service based, license and royalty-free.

Dr. Wieland Wolf, ProBioGen’s CEO commented: “This is the 1st Trastuzumab molecule which will be produced locally for the Indonesian market to provide effective modern medicines for a country of 250 million people. We are proud to be a partner of the well-established and experienced Bio Farma, a government company with a successful history of more than 120 years.”

Dr. Gabriele Schneider, Vice President Business Development of ProBioGen added: “The task to develop high-quality therapeutic proteins with high productivity but low commercial-scale production costs fits very well to our passion for developing intelligent biopharmaceutical solutions, based on our in-house CHO manufacturing platform of adapted cells, robust and economical process development know-how and chemically defined media platform.”

Dr. Iskandar, President Director of Bio Farma stated “Bio Farma is proud to be collaborating with ProBioGen. This collaboration will undoubtedly enhance our vision to enter lifescience industry, where in future it will contribute to producing high-quality biopharmaceuticals particulary for the Indonesian people and others in the world.”

Advertisement